1. Coexisting Systemic Sclerosis-Polymyositis and Sarcoidosis: Case Report and Review of the Literature. Issue 4 (June 2018) Authors: Carmi, Or; Berla, Maya; Edelstein, Evgeny; Levy, Yair Journal: Journal of clinical rheumatology Issue: Volume 24:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224–233]. (1st June 2023) Authors: Moskovich, Dotan; Alfandari, Adi; Finkelshtein, Yael; Weisz, Avivit; Katzav, Aviva; Kidron, Debora; Edelstein, Evgeny; Veroslavski, Daniel; Perets, Ruth; Arbib, Nissim; Kadan, Yfat; Fishman, Ami; Lerer, Bernard; Ellis, Martin; Ashur-Fabian, Osnat Journal: Cancer letters Issue: Volume 563(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer. (31st March 2021) Authors: Moskovich, Dotan; Alfandari, Adi; Finkelshtein, Yael; Weisz, Avivit; Katzav, Aviva; Kidron, Debora; Edelstein, Evgeny; Veroslavski, Daniel; Perets, Ruth; Arbib, Nissim; Kadan, Yfat; Fishman, Ami; Lerer, Bernard; Ellis, Martin; Ashur-Fabian, Osnat Journal: Cancer letters Issue: Volume 501(2021) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Galectin-3 levels are elevated following nintedanib treatment. (November 2020) Authors: Shochet, Gali Epstein; Pomerantz, Alon; Shitrit, David; Bardenstein-Wald, Becky; Ask, Kjetil; Surber, Mark; Rabinowicz, Noa; Levy, Yair; Benchetrit, Sydney; Edelstein, Evgeny; Zitman-Gal, Tali Journal: Therapeutic advances in chronic disease Issue: Volume 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Integrin alpha-5 silencing leads to myofibroblastic differentiation in IPF-derived human lung fibroblasts. (June 2020) Authors: Shochet, Gali Epstein; Brook, Elizabetha; Bardenstein-Wald, Becky; Grobe, Hanna; Edelstein, Evgeny; Israeli-Shani, Lilach; Shitrit, David Journal: Therapeutic advances in chronic disease Issue: Volume 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗